Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART).
Shiga Microalbuminuria Reduction Trial (SMART) Group; Uzu T, Sawaguchi M, Maegawa H, Kashiwagi A. Shiga Microalbuminuria Reduction Trial (SMART) Group, et al. Among authors: maegawa h. Diabetes Care. 2007 Jun;30(6):1581-3. doi: 10.2337/dc06-2493. Epub 2007 Mar 15. Diabetes Care. 2007. Retraction in: Diabetes Care. 2014;37(3):888. doi: 10.2337/dc14-rt03. PMID: 17363751 Retracted. Clinical Trial. No abstract available.
Impaired peripheral circulation in lower-leg arteries caused by higher arterial stiffness and greater vascular resistance associates with nephropathy in type 2 diabetic patients with normal ankle-brachial indices.
Yoshimura T, Suzuki E, Ito I, Sakaguchi M, Uzu T, Nishio Y, Maegawa H, Morikawa S, Inubushi T, Hisatomi A, Fujimoto K, Takeda J, Kashiwagi A. Yoshimura T, et al. Among authors: maegawa h. Diabetes Res Clin Pract. 2008 Jun;80(3):416-23. doi: 10.1016/j.diabres.2008.01.023. Epub 2008 Mar 11. Diabetes Res Clin Pract. 2008. PMID: 18336947
Impact of renin-angiotensin system inhibition on microalbuminuria in type 2 diabetes: a post hoc analysis of the Shiga Microalbuminuria Reduction Trial (SMART).
Shiga Microalbuminuria Reduction Trial (SMART) Group; Uzu T, Sawaguchi M, Maegawa H, Kashiwagi A. Shiga Microalbuminuria Reduction Trial (SMART) Group, et al. Among authors: maegawa h. Hypertens Res. 2008 Jun;31(6):1171-6. doi: 10.1291/hypres.31.1171. Hypertens Res. 2008. Retraction in: Hypertens Res. 2014 Jun;37(6):598. doi: 10.1038/hr.2014.69. PMID: 18716365 Retracted. Clinical Trial.
Membrane localization of protein-tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression and consequent hypertriglyceridaemia.
Ugi S, Shi K, Nishio Y, Shimizu S, Guo B, Sekine O, Ikeda K, Egawa K, Yoshizaki T, Nagai Y, Koya D, Takada T, Torii R, Kimura H, Kashiwagi A, Maegawa H. Ugi S, et al. Among authors: maegawa h. J Biochem. 2009 Oct;146(4):541-7. doi: 10.1093/jb/mvp104. Epub 2009 Jul 15. J Biochem. 2009. PMID: 19605464
481 results